Désolé, cet article est seulement disponible en anglais américain.
Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Présentation
Anciennes Équipes
Publications
Télécharger-
2023Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages., iScience 2023 Apr; 26(4): 106413.
-
2023Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors., RSC Med Chem 2023 Mar; 14(3): 507-519.
-
2022Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2., J Exp Med 2022 Jul; 219(7): .
-
2022A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors., Antiviral Res 2022 May; 201(): 105272.
-
2021Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential., Nat Commun 2021 09; 12(1): 5553.
-
2021SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution., Nat Microbiol 2021 09; 6(9): 1188-1198.
-
2021Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues., Nat Commun 2021 05; 12(1): 3100.